Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Congenital Abnormalities 1Blast Crisis 1

Interventions

fludarabine phosphate 31Peripheral Blood Stem Cell Transplantation 26Cyclophosphamide 25Mycophenolic Acid 24Whole-Body Irradiation 23Busulfan 21Tacrolimus 19Cyclosporine 19Antilymphocyte Serum 14Methotrexate 13Imatinib Mesylate 12Cord Blood Stem Cell Transplantation 11Melphalan 10Dasatinib 10Cyclosporins 8nilotinib 7Methylprednisolone 7Etoposide 7Radiotherapy 6Filgrastim 6Alemtuzumab 6Sirolimus 5thymoglobulin 4sargramostim 4bosutinib 4Granulocyte Colony-Stimulating Factor 4Cytarabine 4fludarabine 3Thiotepa 3Rituximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Chronic-Phase × Homoharringtonine × Clear all
NCT00114959 2015-01-15

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
15 enrolled 6 charts
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡